Gene Silencing Market Expected to Reach $11.31 Billion by 2034 Driven by Advancements in RNA-Based Therapeutics and Precision Medicine
Market Overview The Gene Silencing Market is evolving as a transformative segment within biotechnology, focused on suppressing gene expression to better understand biological pathways and treat complex diseases. Technologies such as RNA interference, antisense oligonucleotides, and CRISPR-Cas9 are at the …